Selzentry and Osteoporosis - a phase IV clinical study of FDA data
Summary:
Osteoporosis is reported as a side effect among people who take Selzentry (maraviroc), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Norvir, and have Gastroesophageal reflux disease.
The phase IV clinical study analyzes which people have Osteoporosis when taking Selzentry. It is created by eHealthMe based on reports of 690 people who have side effects when taking Selzentry from the FDA, and is updated regularly.
What is Selzentry?
Selzentry has active ingredients of maraviroc. It is often used in hiv infection. eHealthMe is studying from 710 Selzentry users. Check the latest studies of Selzentry.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,811 drugs and 1,902 conditions by eHealthMe. Check the latest studies of Osteoporosis.
690 people reported to have side effects when taking Selzentry.
Among them, 47 people (6.81%) have Osteoporosis.

Among these 47 people:
How long have people been on Selzentry when they have Osteoporosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 83.33 %
- 5 - 10 years: 16.67 %
- 10+ years: 0.0 %
What is the gender of people who have Osteoporosis when taking Selzentry? *
- female: 19.15 %
- male: 80.85 %
What is the age of people who have Osteoporosis when taking Selzentry? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 18.75 %
- 50-59: 75.0 %
- 60+: 6.25 %
What are other drugs people take besides Selzentry? *
- Norvir: 37 people, 78.72%
- Viread: 32 people, 68.09%
- Truvada: 31 people, 65.96%
- Isentress: 31 people, 65.96%
- Prezista: 31 people, 65.96%
- Sustiva: 24 people, 51.06%
- Kaletra: 22 people, 46.81%
- Epivir: 21 people, 44.68%
- Tivicay: 20 people, 42.55%
- Combivir: 19 people, 40.43%
What are other side effects people have besides Osteoporosis? *
- Emotional Distress: 47 people, 100.00%
- Pain: 46 people, 97.87%
- Stress And Anxiety: 42 people, 89.36%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 38 people, 80.85%
- Bone Density Decreased: 32 people, 68.09%
- Chronic Kidney Disease: 23 people, 48.94%
- Osteopenia (a condition where bone mineral density is lower than normal): 23 people, 48.94%
- Depression: 19 people, 40.43%
- Fatigue (feeling of tiredness): 18 people, 38.30%
- Gait Disturbance: 15 people, 31.91%
What are the existing conditions these people have? *
- Stress And Anxiety: 8 people, 17.02%
- Pain: 8 people, 17.02%
- Depression: 8 people, 17.02%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 17.02%
- High Blood Pressure: 5 people, 10.64%
- High Blood Cholesterol: 5 people, 10.64%
- Urinary Tract Disorder: 4 people, 8.51%
- Asthma: 4 people, 8.51%
- Bacterial Infection: 4 people, 8.51%
- Bone Pain: 4 people, 8.51%
* Approximation only. Some reports may have incomplete information.
Do you take Selzentry and have Osteoporosis?
- Check whether Osteoporosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Selzentry:
- Selzentry (710 reports)
Osteoporosis treatments and more:
- Osteoporosis (290,734 reports)
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of maraviroc:
- Osteoporosis and drugs with ingredients of maraviroc (60 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Selzentry:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Osteoporosis:
- Osteoporosis (1,811 drugs)
Browse all the conditions that are associated with Osteoporosis:
- Osteoporosis (1,902 conditions)
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on maraviroc (the active ingredients of Selzentry) and Selzentry (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amlodipine cause Extravasation? - 30 seconds ago
- Could Vx-950 cause Fainting? - 32 seconds ago
- Could Lamictal cause Dry Mouth? - 53 seconds ago
- Could Lexiscan cause Joint Pain? - a minute ago
- Could Orudis cause Fever? - a minute ago
- Could Omnicef cause Clostridium Difficile Colitis? - a minute ago
- Depression and Appetite Disorder - a minute ago
- Maxidex vs. Capoten, side effect and effectiveness comparison - 2 minutes ago
- Could Furosemide cause Methaemoglobinaemia? - 2 minutes ago
- Could Dilaudid cause Coughing Up Blood? - 2 minutes ago